drugset / Trial / NCT06845306

The Use of Indocyanine Green Near-infrared Fluorescence for Bowel Perfusion Quantitative Assessment in Order to Prevent Anastomotic Leakage in Colorectal Surgery

NCT06845306

Phase 3 Not yet recruiting 1268 enrolled Vadim Kuznetsov
RandomizedParallel-groupSingle-blindTreatment

Summary

Anastomotic leakage (AL) is a serious complication after surgery for colon cancer, leading to a significant increase in mortality.Intraoperative fluorescence imaging using indocyanine green has proven to be a feasible and reproducible technique for real-time perfusion assessment. An increasing number of studies are being published on the use of indocyanine green (ICG) fluorescence imaging in colorectal cancer surgery, showing promising results. Therefore, we propose conducting a multicenter, randomized controlled trial to investigate the potential use of quantitative assessment of near-infrared fluorescence imaging with indocyanine green (ICG) to prevent anastomotic leaks during colorectal surgery.

Timeline

Start
2025-06-01
Primary completion
2026-07-01
Completion
2026-09-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Indocyanine Green Diagnostic / imaging agent